Moreover, 15% of them were taking LAMA or LABA therapies in combination with inhaled corticosteroids ... company's lead drug candidate into the large COPD market in late 2023 or 2024.

The Spanish COPD guidelines recommend treatment ... a long-acting muscarinic receptor antagonists (LAMA) to ICS + long-acting b2 agonist (LABA) combination for 'triple therapy'.

For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporte ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

RAs, and DPP-4is may offer benefits for patients with COPD, but clinical evidence comparing their effectiveness in reducing ...

Higher costs in the Medicare group may also be explained by the increased prevalence of chronic obstructive pulmonary disease (COPD) or chronic bronchitis in the elderly; however, these conditions ...

Graham Aviation Sales is offering a selection of Bell 206LR helicopters for sale that are not currently on the market. These helicopters are registered for commercial use and have been maintained by a ...